<DOC>
	<DOCNO>NCT02586233</DOCNO>
	<brief_summary>This Phase 1b/2 , double-blind ( Principal Investigators study subject blind , Sponsor unblinded ) , placebo-controlled , randomize , single-ascending dose , multi-center study ass safety , tolerability , pharmacokinetics ( PK ) , pharmacodynamics ( PD ) DS-1040b subject Acute Ischemic Stroke ( AIS ) .</brief_summary>
	<brief_title>Study Assess Safety , Pharmacokinetics , Pharmacodynamics DS-1040b Subjects With Acute Ischemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>Men woman 18 year age old . Subjects clinical diagnosis acute ischemic stroke ( include lacunar stroke ) support computed topography magnetic resonance imaging . Subjects stroke symptom onset within 4.5 12 hour initiation study drug administration . For subject wakeup stroke , symptom onset time refers last time subject know well . Subjects NIHSS score â‰¥ 2 . Subjects , ( legally authorize representativewhere applicable base countryspecific practice ) , must give write informed consent participate study prior participate studyrelated procedure . A separate write informed consent require collect blood sample genotyping . Subjects treat anticipated treated tissue plasminogen activator and/or endovascular thrombectomy current stroke . Eligible subject decline treatment enrol study . Subjects evidence intracranial hemorrhage noncontrast compute tomography ( CT ) ( magnetic resonance [ MR ] ) . Subjects symptoms subarachnoid hemorrhage , even normal CT . Subjects Alberta Stroke Program Early CT Score ( ASPECTS ) &lt; 6 . Subjects prior nontraumatic intracranial hemorrhage ( exclude microhemorrahages observe image ) . Subjects know arteriovenous malformation aneurysm . Subjects evidence active bleeding . Subjects platelet count &lt; 100,000 . Subjects International Normalized Ratio &gt; 1.7 . Subjects use unfractionated heparin within 24 hour prior treatment elevate partial thromboplastin time . Subjects use nonvitamin K antagonist oral anticoagulant dabigatran , rivaroxaban , apixaban , factor Xa inhibitor within 24 hour prior treatment . Subjects use fondaparinux low molecular weight heparin anticoagulation dose within 24 hour prior treatment . Subjects anticipate use anticoagulation dose heparin , fondaparinux low molecular weight heparin , nonvitamin K antagonist oral anticoagulant dabigatran , rivaroxaban , apixaban , factor Xa inhibitor within 48 hour randomization . Low dose heparin low molecular weight heparin preventive dose allow 24 hour treatment start confirmation intracranial bleed 24hours repeat brain imaging . Subjects blood pressure &gt; 185/110 mmHg , require aggressive medication maintain blood pressure limit ( routine medical treatment allow low blood pressure limit ) . Subjects intracranial surgery , clinically significant head trauma ( opinion Principal Investigator ) , Alteplase treatment , previous stroke within 1 month . Subjects major surgery within 14 day . Subjects gastrointestinal genitourinary bleeding last 21 day . Subjects lumbar puncture ( epidural steroid injection ) within 14 day . Subjects preexist disability classify mRS &gt; 2 . Subjects estimate glomerular filtration rate ( use Modification Diet Renal Disease equation ) &lt; 60 mL/min/1.73 m2 . Subjects baseline hemoglobin &lt; 10.5 g/dL . Subjects positive pregnancy test . Serum urine pregnancy test perform ( accord sitespecific practice ) woman childbearing potential ( childbearing potential assume woman 55 year age ) . Subject currently participate another investigational study participate investigational drug study within 30 day 5 halflives investigational drug prior administration study drug . Subject employee immediate family member employee Sponsor , CRO ( ( INC Research ) , Site . Any reason , opinion Investigator , preclude subject participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Acute Ischemic Stroke anterior circulation</keyword>
</DOC>